{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:35:48Z","timestamp":1779914148619,"version":"3.53.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Pre-eclampsia is a serious consideration for women with type 1 diabetes mellitus (T1DM) planning pregnancy. Risk stratification strategies, such as biomarkers measured in the first trimester of pregnancy, could help identify high-risk women. The literature on T1DM-specific pre-eclampsia biomarkers is expanding. We aimed to provide a narrative review of recently published evidence to identify the most promising biomarker candidates that could be targeted for clinical implementation in existing PE models.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A search using MeSH terms was carried out of Medline, EMBASE, Maternity and Infant Care, Web of Science, and Scopus for relevant papers published since 2015 inclusive and in English. The time limit was applied from the publication of the preceding systematic review in this field. Included studies had pre-eclampsia as a primary outcome, measured one or more serum, plasma or urine biomarkers at any time during pregnancy, and had a distinct group of women with T1DM who developed pre-eclampsia. Studies with pre-eclampsia as a composite outcome were not considered. No restrictions on study types were applied. A narrative synthesis approach was adopted for analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 510 records were screened yielding 18 eligible studies relating to 32 different biomarkers. Higher first-trimester levels of HbA1c and urinary albumin were associated with an increased risk of pre-eclampsia development in women with T1DM. Urinary neutrophil gelatinase-associated lipocalin and adipokines were novel biomarkers showing moderate predictive ability before 15 gestational weeks. Two T1DM-specific pre-eclampsia prediction models were proposed, measuring adipokines or urinary neutrophil gelatinase-associated lipocalin together with easily attainable maternal clinical characteristics. Contradicting previous literature, pre-eclampsia risk in women with T1DM was correlated with vitamin D levels and atherogenic lipid profile in the context of haptoglobin phenotype 2-2. Pregnancy-associated plasma protein-A and soluble endoglin did not predict pre-eclampsia in women with T1DM, and soluble Fms-like tyrosine kinase 1 only predicted pre-eclampsia from the third trimester.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Maternally derived biomarkers reflecting glycemic control, insulin resistance and renal dysfunction performed better as PE predictors among women with T1DM than those derived from the placenta. These biomarkers could be trialed in current PE prediction algorithms to tailor them for women with T1DM.<\/jats:p>","DOI":"10.3389\/fbioe.2022.809528","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:43:10Z","timestamp":1654076590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature"],"prefix":"10.3389","volume":"10","author":[{"given":"Katrina Z.","family":"Freimane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kerrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly-Ann","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study","volume":"71","author":"Agrawal","year":"2017","journal-title":"Hypertension"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1097\/aog.0000000000002960","article-title":"ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus","volume":"132","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/dc10-2145","article-title":"Serum Carotenoids and Fat-Soluble Vitamins in Women with Type 1 Diabetes and Preeclampsia","volume":"34","author":"Azar","year":"2011","journal-title":"Diabetes Care"},{"key":"B4","first-page":"S52","article-title":"Microangiopathy and Pregnancy","volume":"66","author":"Azzoug","year":"2016","journal-title":"J. Pak Med. Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nutres.2015.04.004","article-title":"Trace Elements as Predictors of Preeclampsia in Type 1 Diabetic Pregnancy","volume":"35","author":"Basu","year":"2015","journal-title":"Nutr. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and Molecular Cell Biology of Diabetic Complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/nejm199803123381101","article-title":"Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk","volume":"338","author":"Caritis","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.preghy.2013.09.001","article-title":"The Risk of Preeclampsia beyond the First Pregnancy Among Women with Type 1 Diabetes Parity and Preeclampsia in Type 1 Diabetes","volume":"4","author":"Castiglioni","year":"2014","journal-title":"Pregnancy Hypertens. Int. J. Women's Cardiovasc. Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preghy.2018.04.004","article-title":"Glycated Haemoglobin A1c as a Predictor of Preeclampsia in Type 1 Diabetic Pregnant Women: A Systematic Review and Meta-Analysis","volume":"14","author":"Cavero-Redondo","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First Trimester Preeclampsia Screening and Prediction","volume":"226","author":"Chaemsaithong","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":"Pregnancy Outcome in Type 1 Diabetic Women with Microalbuminuria","volume":"24","author":"Ekbom","year":"2001","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.conctc.2019.100465","article-title":"Investigating the Role of Early Low-Dose Aspirin in Diabetes: A Phase III Multicentre Double-Blinded Placebo-Controlled Randomised Trial of Aspirin Therapy Initiated in the First Trimester of Diabetes Pregnancy","volume":"16","author":"Finnegan","year":"2019","journal-title":"Contemp. Clin. Trials Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/09513590.2020.1749998","article-title":"Preeclampsia and Other Pregnancy Outcomes in Nulliparous Women with Type 1 Diabetes: a Retrospective Survey","volume":"36","author":"Garey","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00125-006-0544-5","article-title":"Pre-eclampsia but Not Pregnancy-Induced Hypertension Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetic Women","volume":"50","author":"Gordin","year":"2007","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00592-012-0415-0","article-title":"Pre-eclampsia and Pregnancy-Induced Hypertension Are Associated with Severe Diabetic Retinopathy in Type 1 Diabetes Later in Life","volume":"50","author":"Gordin","year":"2013","journal-title":"Acta Diabetol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-Analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.17772\/gp\/2065","article-title":"Insulin Resistance in Pregnancy Complicated by Type 1 Diabetes Mellitus. Do We Know Enough?","volume":"86","author":"Gutaj","year":"2015","journal-title":"Ginekol. Pol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00592-017-1053-3","article-title":"Determinants of Preeclampsia in Women with Type 1 Diabetes","volume":"54","author":"Gutaj","year":"2017","journal-title":"Acta Diabetol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/1471-0528.16361","article-title":"Implementation of Routine First Trimester Combined Screening for Pre-eclampsia: a Clinical Effectiveness Study","volume":"128","author":"Guy","year":"2020","journal-title":"Bjog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1152\/ajpendo.00020.2005","article-title":"Increased Plasma Levels of Adipokines in Preeclampsia: Relationship to Placenta and Adipose Tissue Gene Expression","volume":"290","author":"Haugen","year":"2006","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"B21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-2007-994340","article-title":"Strategies for Reducing the Frequency of Preeclampsia in Pregnancies with Insulin-dependent Diabetes Mellitus","volume":"13","author":"Hsu","year":"1996","journal-title":"Am. J. Perinatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1507\/endocrj.k10e-045","article-title":"Hyperglycemia Perturbs Biochemical Networks in Human Trophoblast BeWo Cells","volume":"57","author":"Inadera","year":"2010","journal-title":"Endocr. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2393-6-30","article-title":"Poor Glycated Haemoglobin Control and Adverse Pregnancy Outcomes in Type 1 and Type 2 Diabetes Mellitus: Systematic Review of Observational Studies","volume":"6","author":"Inkster","year":"2006","journal-title":"BMC Pregnancy Childbirth"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/14767058.2020.1743658","article-title":"Are the First-Trimester Levels of PAPP-A and Fb-hCG Predictors for Obstetrical Complications in Diabetic Pregnancy?","volume":"35","author":"Kapustin","year":"2020","journal-title":"J. Maternal Fetal Neonatal Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/nu12072048","article-title":"Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes","volume":"12","author":"Kelly","year":"2020","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/dc17-1635","article-title":"Subclinical First Trimester Renal Abnormalities Are Associated with Preeclampsia in Normoalbuminuric Women with Type 1 Diabetes","volume":"41","author":"Kelly","year":"2018","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1007\/s00125-017-4415-z","article-title":"Circulating Adipokines Are Associated with Pre-eclampsia in Women with Type 1 Diabetes","volume":"60","author":"Kelly","year":"2017","journal-title":"Diabetologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1210\/jc.2019-00723","article-title":"Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women with Type 1 Diabetes","volume":"104","author":"Kelly","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","article-title":"Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes","volume":"30","author":"Kilpatrick","year":"2007","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of Circulating Placental Growth Factor, Vascular Endothelial Growth Factor, Soluble Fms-like Tyrosine Kinase 1 and Soluble Endoglin in the Prediction of Pre-eclampsia: a Systematic Review and Meta-Analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"Bjog"},{"key":"B31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00125-015-3787-1","article-title":"White's Classification and Pregnancy Outcome in Women with Type 1 Diabetes: a Population-Based Cohort Study","volume":"59","author":"Klemetti","year":"2016","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and Clinical Significance of Haptoglobin Polymorphism in Humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/09513590.2015.1134477","article-title":"IGF-1 Is Associated with Fetal Growth and Preterm Delivery in Type 1 Diabetic Pregnancy","volume":"32","author":"Lauszus","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11892-015-0586-5","article-title":"Vascular Complications in the Diabetic Pregnancy","volume":"15","author":"Leguizam\u00f3n","year":"2015","journal-title":"Curr. Diab Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/nejmoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/(sici)1096-9136(199712)14:12<1059::aid-dia505>3.0.co;2-8","article-title":"Pre-eclampsia Is a Potent Risk Factor for Deterioration of Retinopathy during Pregnancy in Type 1 Diabetic Patients","volume":"14","author":"L\u00f6vestam-Adrian","year":"1997","journal-title":"Diabet. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2337\/dc14-1755","article-title":"Glycemic Targets in the Second and Third Trimester of Pregnancy for Women with Type 1 Diabetes","volume":"38","author":"Maresh","year":"2015","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2337\/dc16-1647","article-title":"Pregnancy Outcomes in Women with Diabetes-Lessons Learned from Clinical Research: The 2015 Norbert Freinkel Award Lecture","volume":"39","author":"Mathiesen","year":"2016","journal-title":"Diabetes Care"},{"key":"B39","volume-title":"Hypertension in Pregnancy: Diagnosis and Management","year":"2019"},{"key":"B40","volume-title":"Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period","year":"2015"},{"key":"B41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jash.2017.12.003","article-title":"Urine Albumin Is a Superior Predictor of Preeclampsia Compared to Urine Plasminogen in Type I Diabetes Patients","volume":"12","author":"Nielsen","year":"2018","journal-title":"J. Am. Soc. Hypertens."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e3176","DOI":"10.1002\/dmrr.3176","article-title":"Impaired Awareness of Hypoglycaemia: A New Risk Factor for Adverse Pregnancy Outcomes in Type 1 Diabetes","volume":"35","author":"Perea","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/nu13113854","article-title":"Could Vitamin D Be Effective in Prevention of Preeclampsia?","volume":"13","author":"Poniedzia\u0142ek-Czajkowska","year":"2021","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/hypertensionaha.108.127977","article-title":"First-Trimester Prediction of Hypertensive Disorders in Pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"B45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/uog.18899","article-title":"Early Screening and Prevention of Preterm Pre-eclampsia with Aspirin: Time for Clinical Implementation","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/nejmoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/s0002-9378(11)90608-5","article-title":"Progression of Diabetic Retinopathy in Pregnancy: Association with Hypertension in Pregnancy","volume":"166","author":"Rosenn","year":"1992","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bpobgyn.2014.09.008","article-title":"Metabolic Disorder of Pregnancy (Understanding Pathophysiology of Diabetes and Preeclampsia)","volume":"29","author":"Salzer","year":"2015","journal-title":"Best Pract. Res. Clin. Obstetrics Gynaecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/s2214-109x(14)70227-x","article-title":"Global Causes of Maternal Death: a WHO Systematic Analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ajog.2020.01.020","article-title":"A New Model for Screening for Early-Onset Preeclampsia","volume":"222","author":"Serra","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/hypertensionaha.118.11191","article-title":"Cardiovascular System in Preeclampsia and beyond","volume":"73","author":"Thilaganathan","year":"2019","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/uog.14811","article-title":"Serum Placental Growth Factor in the Three Trimesters of Pregnancy: Effects of Maternal Characteristics and Medical History","volume":"45","author":"Tsiakkas","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/aogs.13180","article-title":"Vitamin D Insufficiency, Preterm Delivery and Preeclampsia in Women with Type 1 Diabetes - an Observational Study","volume":"96","author":"Vestgaard","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1080\/14767058.2017.1331429","article-title":"Prediction of Preeclampsia in Type 1 Diabetes in Early Pregnancy by Clinical Predictors: a Systematic Review","volume":"31","author":"Vestgaard","year":"2017","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the Prevention of Pre-eclampsia in High-Risk Women: a Randomised Placebo-Controlled PREDO Trial and a Meta-Analysis of Randomised Trials","volume":"120","author":"Villa","year":"2013","journal-title":"Bjog"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/1471-0528.12288","article-title":"Haptoglobin Phenotype, Pre-eclampsia, and Response to Supplementation with Vitamins C and E in Pregnant Women with Type-1 Diabetes","volume":"120","author":"Weissgerber","year":"2013","journal-title":"Bjog"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and Diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr. Diab Rep."},{"key":"B58","first-page":"567","article-title":"Metabolic Syndrome in Type 1 Diabetes Mellitus. Does it Have Any Impact on the Course of Pregnancy?","volume":"62","author":"Wender-Ozegowska","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0002-9343(49)90382-4","article-title":"Pregnancy Complicating Diabetes","volume":"7","author":"White","year":"1949","journal-title":"Am. J. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1210\/jcem.87.4.8405","article-title":"First Trimester Insulin Resistance and Subsequent Preeclampsia: a Prospective Study","volume":"87","author":"Wolf","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"A352","DOI":"10.2337\/dc16-0803","article-title":"Serum FABP4 Predicts Preeclampsia in Pregnant Women with Type 1 Diabetes","volume":"65","author":"Wotherspoon","year":"2016","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jdiacomp.2016.02.001","article-title":"Evaluation of Biomarkers for the Prediction of Pre-eclampsia in Women with Type 1 Diabetes Mellitus: A Systematic Review","volume":"30","author":"Wotherspoon","year":"2016","journal-title":"J. Diabetes its Complicat."},{"key":"B63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tjog.2018.08.008","article-title":"Association of the Presence of Microangiopathy with Adverse Pregnancy Outcome in Type 1 Diabetes: A Meta-Analysis","volume":"57","author":"Xiang","year":"2018","journal-title":"Taiwan. J. Obstetrics Gynecol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/dc19-0967","article-title":"Urinary and Serum Angiogenic Markers in Women with Preexisting Diabetes during Pregnancy and Their Role in Preeclampsia Prediction","volume":"43","author":"Zen","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.809528\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:43:15Z","timestamp":1654076595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.809528\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":64,"alternative-id":["10.3389\/fbioe.2022.809528"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2022.809528","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"article-number":"809528"}}